Recent Finacing
Recent Raise
Anvesana develops mRNA-targeted therapeutics and operates an RNA-sequence analysis platform with a distributed database, proprietary 250,000-annotation reference transcriptome, and algorithms to prioritize targets and filter artifacts.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor